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ABSTRACT  
 
Circulating aldosterone levels are increased in human pregnancy. Inadequately low 
aldosterone levels as present in preeclampsia, a life-threatening disease for both 
mother and child, are discussed to be involved in its pathogenesis or severity. 
Moreover, inactivating polymorphisms in the aldosterone synthase gene have been 
detected in preeclamptic women. Here, we used aldosterone synthase deficient   
(AS-/-) mice to test whether the absence of aldosterone is sufficient to impair 
pregnancy or even to cause preeclampsia. AS-/- and AS+/+ females were mated with 
AS+/+ and AS-/- males, respectively, always generating AS+/- offspring. With maternal 
aldosterone deficiency in AS-/- mice, systolic blood pressure was low before and 
further reduced during pregnancy with no increase in proteinuria. Yet, AS-/- had 
smaller litters due to loss of fetuses as indicated by a high number of necrotic 
placentas with massive lymphocyte infiltrations at gestational day 18. Surviving 
fetuses and their placentas from AS-/- females were smaller. High salt diet before and 
during pregnancy increased systolic blood pressure only before pregnancy in both 
genotypes and abolished the difference in blood pressure during late pregnancy. 
Litter size from AS-/- was slightly improved and the differences in placental and fetal 
weights between AS+/+ and AS-/- mothers disappeared. Overall an increased 
placental efficiency was observed in both groups paralleled by a normalization of 
elevated HIF1 levels in the AS-/- placentas. Our results demonstrate that 
aldosterone deficiency has profound adverse effects on placental function. High 
dietary salt intake improved placental function. In this animal model, aldosterone 
deficiency did not cause preeclampsia.  
3 
 
Key words: aldosterone, placenta, fetal growth, systolic blood pressure, high salt diet 
4 
 
INTRODUCTION 
 Pregnancy is characterized by a profound volume expansion due to high 
aldosterone levels meant to support fetal well-being [5]. Preeclampsia is a clinical 
syndrome in pregnant women defined as the new onset of hypertension and 
proteinuria after 20 weeks of gestation. It affects 3-5% of all pregnancies and is the 
leading cause of maternal and fetal morbidity and mortality [40]. The etiology of 
preeclampsia is multifactorial. 
Insufficient placental implantation oxidative stress, genetic predisposition, 
natural killer cell dysfunction or preformed agonistic angiotensin II receptor subtype 1 
autoantibodies may contribute to the development of preeclampsia [6, 29, 40]. 
Histologically, preeclampsia is characterized by a defect in the invasion of the 
endovascular trophoblast that may eventually cause reduced blood supply to the 
feto-placental unit [25, 28]. 
Placental ischemia  may trigger the release of vasoactive, angiogenetic and 
antiangiogenetic factors such as vascular endothelial growth factor (VEGF) and 
placental growth factor (PlGF) as well as an enhanced placental expression of the 
angiogeneic receptors fms like tyrosine kinase 1 (Flt-1) and endoglin [22]. Likewise, 
their soluble forms sFlt-1 and sEng are released into systemic circulation leading to  
endothelial dysfunction and increased blood pressure.   
 Normal pregnancy is characterized by a marked expansion of plasma and 
extracellular volume associated with changes in renal hemodynamics as well as in 
the circulating level of adrenal steroid hormones [17, 27], which likely help adapting 
the maternal circulation to the increasing blood and substrate requirements of the 
growing placenta and fetus. Consistently, plasma aldosterone concentrations 
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increase during normal pregnancy coinciding with plasma volume expansion [33, 
38]. In preeclampsia, a reduced plasma volume precedes the onset of and is 
consistently reported to be reduced during the disease associated with a shift of fluid 
from intravascular to interstitial space and edema [9, 12, 14, 38] while plasma 
aldosterone concentration and renin activity are suppressed [37]. This observation 
suggested preeclampsia to be caused or aggravated by an inadequate balance of 
extracellular volume and the activity of the renin-angiotensin-aldosterone system. As 
a substantial group of preeclamptic women also show reduced aldosterone synthase 
enzyme (CYP11B2 gene) activity [35], aldosterone deficiency was implicated to play 
a role in the pathogenesis of preeclampsia. Aldosterone deficiency may lower 
extracellular volume and increase thereby the risk of placental hypoperfusion [35] 
thus indirectly causing the release of vasoactive factors leading to preeclampsia. The 
possible role of aldosterone was further evidenced by the finding that loss- and gain-
of function due to distinct gene variants of CYP11B2 may predispose for or protect 
from preeclampsia, respectively. In fact, the V386A variant of CYP11B2  gene, which 
causes a deficiency in the rate-limiting step of aldosterone synthesis, the 18-
hydroxycorticosterone methyl oxidase activity [30], was observed solely in a 
subgroup of preeclamptic women, but never in normal pregnant women [35]. In 
contrast, the gain of function variants of the CYP11B2 gene in the SF-1 and Int2 (C) 
sites, which have been shown to be associated with hypertension in non-pregnant 
subjects [26], apparently reduce the risk of developing preeclampsia [8]. Recently, 
observations by Gennari-Moser et al. [16] suggested a role of aldosterone in fetal 
perfusion and also in placental growth. Taken together, these studies propose a role 
of aldosterone availability for placental size, fetal perfusion and also the development 
of preeclampsia. Whether these effects of aldosterone are mediated directly via the 
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mineralocorticoid receptor in placental tissue or more indirectly via the regulation of 
NaCl homeostasis and blood pressure regulation has not been fully clarified.  
Aldosterone is closely linked to salt uptake. Of interest, an old clinical study 
forwards the observation of a reduced incidence of preeclampsia and fetal death on 
a high salt diet [32]. In addition, in a hypertensive woman homozygous for the V386A 
CYP11B2 mutation and low aldosterone availability salt supplementation lowered 
SBP throughout pregnancy [10]. However, it is not clear whether aldosterone 
deficiency alone can lead to preeclampsia and whether aldosterone deficiency can 
be counterbalanced by a high salt diet.  
Thus, we examined whether aldosterone deficiency would compromise pregnancy 
and even cause preeclampsia-like symptoms in mice. Using CYP11B2-deficient 
mice (AS-/-) [21], we found that the absence of maternal aldosterone did not cause 
proteinuria or arterial hypertension, two major symptoms of preeclampsia, but 
reduced litter size due to loss of fetuses and severe placenta pathologies during the 
period of pregnancy. Feeding a high salt diet during pregnancy partially rescued this 
defect suggesting that reduced placental perfusion may play an important role. 
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METHODS 
Animals 
 All experiments were performed with inbred 129 SvEv genetic background 
[24] aldosterone synthase wild type (AS+/+) and aldosterone synthase-deficient (AS-/-) 
female mice. This mouse model was generously provided by Prof. Oliver Smithies, 
University of North Carolina, Chapel Hill, NC, USA [21]. Unless indicated otherwise, 
animals were fed standard rodent chow (3430, KLIBA NAFAG, Kaiseraugst, 
Switzerland) with free access to normal tap water. All experiments were performed 
according to Swiss Animal Welfare laws.  
 
Study design and treatment 
 Age matched female AS+/+ and AS-/- mice, between 3.5 to 6.5 months old, 
were used for experiments. Animals were divided into two groups, a control group 
and an experimental group. In the control group, AS-/- male were mated with AS+/+ 
female mice, whereas in the experimental group, AS+/+ male mice were mated with 
AS-/- females to generate only heterozygous pups to have the same genotype for all 
pups. Both groups were fed with either the standard rodent chow powder, (3433 
KLIBA NAFAG, Kaiseraugst, Switzerland) containing 0.20 % Na+ and 0.36 % Cl- 
(control diet) (AS+/+ n = 9 and AS-/- mice n = 9) or with standard diet supplemented 
with NaCl (high salt diet, 5 % NaCl) (AS+/+ n = 6-8 and AS-/- mice n = 8-10). To feed 
the mice with high salt diet, 100 g of standard rodent chow powder was mixed with   
5 g NaCl and then mixed with an equal volume of deionised water to moisten the 
food for feeding. Male and female mice were kept together in individual cages for 
breeding and female mice were controlled daily in the early morning for the presence 
of copulation plugs and the following day was considered as gestational day 1. 
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Systolic blood pressure (SBP) was measured in female mice using the tail cuff 
method (see below). In another set of experiments mice were fed either the control 
diet (AS+/+ n = 8, AS-/- n = 15) or high salt diet (5 % NaCl) (AS+/+ n = 6, AS-/- n = 9) 
and sacrificed on day 18 of pregnancy by cervical dislocation. The number and 
weight of pups and placentas were measured, and tissues collected for further 
analysis. Placentas were collected and rapidly frozen in liquid nitrogen and stored at 
-80oC for RNA extraction. Some placentas were fixed in 4% paraformaldehyde for 
histology. 
  
Tail cuff SBP measurements  
 Systolic BP (SBP) was measured by a non-invasive computerized tail cuff 
method (BP2000, Visitech Systems, Apex, NC, USA) as described previously [20]. 
Mice were adapted for 5 days before the start of the study. This period of adaption 
has been characterized previously for this specific tail cuff method and found to 
reduce stress induced side effects [20]. Blood pressure was measured at the same 
time everyday from 1 pm to 5 pm. Averages of SBP measurements having standard 
deviations less than 10 mmHg were considered for further analysis. Systolic blood 
pressure from female mice on control diet was measured on control conditions 2 to 3 
days before pregnancy and from day 1 of pregnancy until the end of pregnancy up to 
21 days. Mean SBP was calculated from each day’s average SBP measurements. 
SBP for high salt diet experiments was measured on control diet, then mice were 
given high salt and SBP was measured again after 4 days of high salt diet. 
Thereafter, female mice were kept together with male mice for mating and SBP was 
measured at gestational days 5 to 7 and days 15 to 17. Mean SBP was calculated 
from 3 days of average SBP measurements. 
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Urinary protein concentration measurement: 
 Spot urine was collected from female mice during pregnancy everyday by 
gentle massage of the urinary bladder. Total urinary protein concentration was 
measured with a standard protein assay kit (Biorad Dc Protein Assay, Biorad, 
Hercules, CA, USA). Urinary creatinine concentration was measured by the Jaffe 
method [34]. 
RNA extraction and Semi-quantitative Real-time PCR 
Semi-quantitative real time (qRT-PCR) was performed to assess the expression of  
vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFlt-
1),the hypoxia inducible factor 1α (HIF1α), Tumor Necrosis Factor 1alpha (TNF1), 
and the monocyte chemo-attractant protein 1 (MCP-1). Snap frozen placentas (5 
placentas per group) were homogenized in RLT buffer (Qiagen, Hilden, Germany) 
supplemented with 2-mercaptoethanol to a final concentration of 1 %. Total RNA 
was extracted from 200 µl aliquots of each homogenized sample using RNeasy Mini 
Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Quality 
and concentration of the isolated RNA preparations were measured on a ND-1000 
spectrophotometer (Thermo Fischer Scientific Inc., Wilmington, DE, USA). Total 
RNA samples were stored at -80oC until further use. Each RNA sample was diluted 
to 100 ng/µl and 3 µl was used as a template for reverse transcription using the 
TaqMan Reverse Transcription Kit (Applied Biosystems, Forster City, CA). Semi-
Quantitative real time (qRT-PCR) was performed on the ABIPRISM 7500 Sequence 
Detection System (Applied Biosystem, Foster City, CA, USA). Primers for vascular 
endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and the 
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hypoxia inducible factor 1α (HIF1α) were designed using Primer 3 online software, 
whereas primers for hypoxanthine guanine phosphoribosyl transferase (HPRT) and 
GAPDH as housekeeping genes were designed using Primer Express software from 
Applied Biosystem. Sequences of primers are as follows: GAPDH forward 5-
GTCGTGGATCTGACGTGCC-3' and reverse 5′-GATGCCTG CTTCACCACCTT-3', 
VEGF forward 5’-CAGGCTGCTGTAACGATGAA-3’ and reverse 5’-GCA 
TTCACATCTGCTGTGCT-3’, sFlt forward 5’-GGGAAGACATCCTTCGGAAGA-3’ 
and reverse 5’-TGTGGTACAATCATTCCTCCTG-3’, HIF1α forward 5’-
ATCTCGGCGAAGCAAAGAG and reverse 5’-CTGTCTAGACCACCGGCATC-3’, 
HPRT  forward 5’-TTATCAGACTGAAGAGCTACTGTAAGATC-3 and reverse 5’-
TTACCAGTGTCAATTATATCTTCAACAATC-3’. The primers and probes used from 
Applied Biosystem are  MCP-1 (Mm00441242) and TNFα (Mm99999068). Specificity 
of the primers was first tested in a standard PCR and always resulted in a single 
product of the expected size on 2% agarose gel. Real time PCR reactions were 
performed using the iQ SYBR Green Supermix (Biorad, Hercules, CA, USA). ROX 
Passive reference Dye (Biorad, Hercules, CA, USA) 3.3 µl/ 1.25 ml of iQ SYBR 
Green Supermix was added. Briefly, 3 µl cDNA, 0.8 µl of each primer (10 µM), 5.4 µl 
RNase free water, 10 µl iQ SYBR Green Supermix were mixed to 20 µl final reaction 
volume. Reaction conditions were: denaturation at 95oC for 10 min followed by 40 
cycles of denaturation at 95oC for 15 s and annealing/elongation at 60oC for 60 s 
followed by dissociation stage (95oC for 15 s, 60oC for 15 s followed by a slow ramp 
to 95oC). All reactions were run in duplicate. The expression of gene of interest was 
calculated in relation to HPRT. Relative expression ratios were calculated as R = 
2[Ct(HPRT/_-actin)_Ct(test gene)]. 
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Histology  
 Placentas were fixed by immersion in 4% paraformaldehyde (Applichem, 
Darmstadt, Germany). After tissue processing and embedding in paraffin, 5 µm 
sections were prepared. Paraffin sections were stained with hematoxylin-eosine 
(H&E) and scanned with a Mirax Midi Slide Scanner microscope (Zeiss, Jena, 
Germany).  
 
Immunoblotting 
  Placentas, stored at -80°C, were homogenised in ice cold homogenisation 
buffer (0.27 M sucrose, 2 mM EDTA, 0.5 % NP40 prepared in 1x buffer A 
supplemented with protease and phosphatase inhibitor cocktails (Roche, Mannheim, 
Germany) (buffer A: 0.6 M KCl, 150 mM NaCl, 150 mM HEPES, pH 7.5,). 
Homogenates were overlaid on a sucrose cushion (30 % w/v sucrose, 2 mM EDTA, 
pH 8 prepared in 1x buffer A) and centrifuged at 3,000 rpm for 10 minutes at 4°C.  
After centrifugation, supernatant obtained were stored as a cytoplasmic fraction, and 
pellets of nuclei were resuspended in 1x nuclei extraction buffer (20 mM HEPES, pH 
7.5, 400 mM NaCl,  1 mM EDTA, pH 8) and incubated for 15 minutes on ice with 
intermittent vortexing. Solubilised nucleated pellet fractions were centrifuged again at 
15,000 rpm for 5 minutes at 4°C and supernatant collected as nuclear protein 
fraction. Protein concentration was measured by protein assay kit (Bio-rad protein 
assay, Munich, Germany) as per manufactures instructions. 60 to 80 µg of proteins 
were solubilised in 5X Laemmli sample buffer and run on 8% polyacrylamide gels. 
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On some blots, hypoxic (0.2 % oxygen for 16 hours) and normoxic (20 % oxygen for 
16 hours) control samples collected from Mouse Embryonic Fibroblasts (MEFs) cell 
culture were loaded as positive controls (kindly provided by M. Kaufmann and R. 
Wenger, Univ. of Zurich). Briefly protein was separated by SDS-PAGE, transferred 
on nitrocellulose membrane by wet transfer method and incubated overnight with 
following primary antibodies: rabbit polyclonal anti-HIF1α (1:1000, Novus Biologicals) 
and mouse monoclonal β-actin (1:10,000, Sigma). After washing nitrocellulose 
membranes were incubated with anti-rabbit secondary fluorescent antibody (goat 
anti-rabbit IRdye 800 1:10,000, or goat anti mouse IRDye 680, 1:20,000, Li-COR, 
Nebraska, USA). After washing the membranes three times, the protein signal was 
detected by scanning the membrane with the Odyssey Infrared Imaging System (Li-
COR Biosciences). All images were analyzed using analysis software provided with 
the system to calculate the protein of interest/actin ratio. 
 
Statistical analysis 
 Results are expressed as mean ± SEM. All data were tested for significance 
using paired or unpaired Student’s test, one or two way ANOVA analysis followed by 
Tukey’s multiple comparison post test where appropriate. P<0.05 was considered 
statistically significant. 
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RESULTS 
Absence of a maternal preeclamptic phenotype in AS-/- mice during pregnancy  
 To test the hypothesis that aldosterone deficiency during pregnancy may 
contribute to the pathogenesis of preeclampsia, we measured SBP and urinary 
protein excretion in AS+/+ and AS-/- dams before and during pregnancy. In order to 
eliminate the genotype of the fetuses as confounding factor, AS+/+ females were 
mated to AS-/- males and AS-/- females to AS+/+ males producing only AS+/- offspring. 
Before and during pregnancy, SBP was significantly higher in AS+/+ than in AS-/- 
dams (Figure 1A). While blood pressure of AS+/+ remained constant at about 110 
mmHg throughout pregnancy, SBP in AS-/- dams decreased from about 105 mmHg 
at day 1 to about 90 mmHg at day 21. Importantly, there was no difference in urinary 
protein excretion and no increase in AS+/+ and AS-/- mice during pregnancy (Figure 
1B). Thus, AS-/- dams did not become hypertensive and did not develop proteinuria 
during pregnancy.  
 
Presence of a feto-placental phenotype in AS-/- mice on –control diet 
 Mean litter size at birth was lowered in AS-/- dams compared to AS+/+ mice 
(3.0 ± 0.55 vs. 6.22 ± 0.66, respectively; p<0.005) representing a strong fetal 
phenotype (Figure 1C). To examine whether the reduced litter size at birth was due 
to intrauterine death of fetuses, dams were sacrificed on gestational day 18 (E18) 
and the number and weight of fetuses and placentas were measured. The mean 
litter size was again smaller in AS-/- compared to AS+/+ dams (2.67 ± 0.54 vs. 7.13 ± 
0.48, respectively; p<0.0001) (Figure 2A). The reduction of the number of pups 
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paralleled the presence of dark and necrotic placentas in AS-/- mice (Figures 2A and 
2B). Necrotic placentas were mostly observed in series next to each other but 
sometimes also observed interspersed between healthy placentas. Necrotic 
placentas were not seen in any AS+/+ dams on control diet.  
 When the mean litter and placenta weights were plotted against litter sizes 
(Figure 2C), it became evident that the data for the AS-/- mice were not only shifted to 
smaller litter sizes but also to reduced litter and placenta weights. This is most 
evident when litters of the same sizes in AS-/- and in AS+/+ are compared (i.e. litter 
sizes of 5 and 7 pups in figure 2C). In contrast, in very small litters (n=1-3), placental 
weight appeared to be normal. Histological examination of the placentas further 
confirmed the reduced size of placentas in AS-/- dams, but did also reveal that most 
of the placentas were otherwise healthy with a similar structural organization of 
decidua basalis, junctional zone, and labyrinth as in AS+/+ dams (Figure 3A and B, 
left and middle section). Only dark placentas from AS-/- dams showed severe 
coagulative necrosis with lymphocyte infiltrations in all three layers of the placenta 
(Figure 3A and B, right section).  
 
High salt diet does not increase intrauterine survival, but improves fetal 
growth in AS-/- mice, and lowers SBP irrespective of the presence of 
aldosterone 
 Hypothesizing that aldosterone deficiency in AS-/- mice might compromise 
placental perfusion, we tested if replacing renal sodium losses by feeding a high salt 
diet (5 % NaCl) before and during pregnancy may improve SBP, the weight of 
placentas and pups, and litter sizes. AS+/+ and AS-/- females were fed a high salt diet 
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starting 12 days before until the end of pregnancy. After 4 days on a high salt diet, 
SBP rose in both groups of mice, but this increase occurred in parallel and hence 
AS-/-  female mice continued to have lower SBP than AS+/+ female mice (Figure 4A). 
During the first days (days 5-7) of pregnancy, SBP dropped significantly in both AS+/+ 
and AS-/- dams, but the decrease of SBP was much more pronounced in AS+/+ mice 
than in AS-/-  mice. Therefore, the SBP difference between genotypes became very 
small (days 5-7) and was no longer significant on days 15 to 17. This is in contrast to 
the measurements in dams on standard chow, where a significant difference in SBP 
was maintained throughout the entire pregnancy (Figure 1). In AS-/-, blood pressure 
was lower towards the end of gestation irrespective of salt intake (Figure 4B). In 
AS+/+ mice, SBP did not drop significantly in pregnancy on a normal salt diet. 
However, if a high salt diet was provided, blood pressure dropped reaching the 
lowest levels at the end of pregnancy (Figure 4C). Of interest, both a low and a high 
volume state led to a blood pressure reduction in pregnancy with the latter being 
even more consistent throughout pregnancy. 
 The high Na+ diet did neither increase the mean litter size nor decrease the 
number of necrotic placentas in AS-/- dams (Figure 5A). However, the mean weights 
of litters and placentas were no longer different between the genotypes when litters 
of the same sizes were compared (Figure 5B). This contrasts with the standard salt 
intake, when both mean litter and placenta weights were smaller in AS-/- than in AS+/+ 
dams (Figure 2C). Thus high salt intake does not increase the survival rate of 
fetuses, but appears to improve intrauterine growth of surviving pups. 
The beneficial effect of a high salt intake was seen for both genotypes. Although the 
5% NaCl intake did not increase mean placental weight, it significantly improved the 
weight of the fetuses in AS+/+ and AS-/- dams (Figure 6A, B). Consistent with these 
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differential effects on fetal and placental growth, placental efficiency (ratio of fetal 
weight over placental weight) was significantly increased in both AS+/+ and AS-/- 
dams on high salt diet compared to control diet (Figure 6C). Interestingly, placental 
efficiency was not significantly different between AS+/+ and AS-/- dams, neither on 
control nor on high salt diet (Figure 6C).  
 
Expression of the hypoxia inducible factor HIF1α in placentas   
 Preeclampsia is associated with altered expression of key anti- and pro-
angiogenic factors [40]. We did not detect any differences in the mRNA expression 
of HIF1α (Figure 7A), VEGF (Figure 7B), and sFlt (Figure 7C) between healthy 
appearing placentas from AS+/+ and AS-/- dams kept on either a control or a high salt 
diet. Since HIF1α is mostly regulated at the post-translational level by stabilisation 
and degradation of the protein, we performed immunoblots. HIF1α protein 
abundance was significantly increased in healthy placentas from AS-/- dams on 
control diet (Figure 9A). This difference disappeared on high salt diet (Figure 9B). 
HIF1α protein was not detected in necrotic placentas (Figure 9A).  
 
Expression of pro-inflammatory factors in necrotic placentas 
 The MCP-1 and TNFα are key pro-inflammatory cytokines involved in 
inflammatory process. Expression of MCP-1 and TNFα mRNA was significantly 
increased in necrotic placentas from AS-/- dams on control (Figure 8A) and high salt 
diet (Figure 8B) but not in healthy appearing placentas from both genotypes.  
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DISCUSSION 
 Plasma volume expansion in the presence of high aldosterone levels is 
considered crucial for healthy pregnancies, both of which are low in the most severe 
form of hypertensive pregnancies, preeclampsia. In order to examine the role of 
aldosterone in the development of preeclampsia, we used an aldosterone synthase 
knockout mouse model (AS-/-). AS-/- mice have a compensatory increase of renin and 
angiotensin II to supraphysiological concentrations but no aldosterone [21] allowing 
to independently test the role of aldosterone in pregnancy. Additional effects of these 
high renin and angiotensin II may occur but could not be tested because survival of 
AS-/- mice depends on high angiotensin II levels and pharmacological blockade of 
AT1 receptors is lethal in AS-/- mice (unpublished observations).  
 New-onset hypertension and proteinuria with feto-placental developmental 
disturbances are considered to be cardinal features of preeclampsia [40]. We found 
that AS-/- dams did not develop preeclampsia as suggested by the absence of 
hypertension and proteinuria during pregnancy. A previous study measured SBP by 
telemetry during pregnancy and showed no change in SBP during the first 5 days, 
followed by a drop in SBP from days 6 to12, and again from day 15 to 17 of 
pregnancy [4]. In our hands, using the less sensitive tail cuff method, we found 
reduced SBP in wild type mice during pregnancy in response to salt loading. Though 
contra-intuitive, this observation is in line with some clinical observations during salt 
loading in pregnancy suggesting a beneficial systemic feedback on maternal 
hemodynamics upon optimal placental perfusion [10, 32]. Thus, preeclampsia is not 
caused by a lack of aldosterone alone, at least in mice.  
18 
 
 However, the mouse model revealed a number of other interesting 
observations demonstrating an important role of aldosterone in normal pregnancy. 
AS-/- dams were hypotensive before pregnancy and became even more hypotensive 
during mid to term pregnancy. The resulting feto-placental phenotype of a decreased 
litter size and smaller or necrotic placentas without fetuses at term suggests a 
severe placental hypoperfusion.  The sum of intact fetuses and necrotic placentas in 
AS-/- mice was similar to the average number of fetuses in AS+/+ dams, indicating 
that AS-/- dams were able to conceive normally but had impaired placental 
development and function, predisposing to intrauterine death. The few normal weight 
placentas and fetuses observed in AS-/- dams carrying small litters would such 
provide a residual blood and nutrient supply to the remaining placentas.  
 Histological examination of healthy placentas from AS-/- dams demonstrated 
normal structural patterns but reduced size. One important reason for lower placental 
weight might be the absence of direct effects of aldosterone on the placenta in AS-/- 
dams. In-vitro experiments have  revealed a direct role for aldosterone in the 
modulation of trophoblast  growth and placental size [16] and in-vivo studies in ewes 
suggested a role of aldosterone in placental growth [19]. Placental size in rats and 
humans is positively correlated with plasma levels of aldosterone [16]. Thus, 
aldosterone may positively modulate placental growth, similar to its proliferative 
capabilities in organs such as the heart and the kidney [36, 39].  
 Reduced fetal weight in AS-/- dams might thus be due to placental 
insufficiency. In normal human pregnancy, plasma volume expansion is associated 
with increased plasma aldosterone level whereas both were decreased in 
pregnancies with intrauterine growth restriction and preeclampsia [33]. Preeclampsia 
is characterised by extracellular volume expansion but low intravascular volume 
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which is caused at least in part by a shift of fluid from the intravascular to the 
interstitial fluid space due to vasoconstriction and leaky endothelium [12-13, 31]. 
Lack of aldosterone in  AS-/- dams might thus critically impair plasma volume 
expansion and thereby cause reduced uterine blood supply similar to functional 
aldosterone deficiency in mice chronically exposed to the mineralcorticoid receptor 
antagonist spironolactone during pregnancy which led to reduced fetal umbilical 
blood flow [16]. Moreover, modelling a reduced uterine blood supply by constriction 
of the uterine artery in rats from gestational day 14 caused placental insufficiency 
resulting in low-birth weight [2].  
 One common cause for the decreased litter size, reduced fetal and placental 
weight, and necrotic and inflammatory placentas in AS-/- dams could be hypoxia. In 
rats, hypoxia during the last 11 days of pregnancy results in smaller sized litters, 
decreased placental and fetal weights, and placental resorption [18]. Low oxygen 
tension affects cytotrophoblast proliferation and invasion and ultimately fetal growth 
[15]. Consistently, the hypoxia-induced factor HIF1, a master regulator in the 
adaption to hypoxia, is essential for mammalian placentation [1]. HIF1α protein 
abundance was significantly higher in AS-/- mice on control diet, but was reduced to 
control levels on 5% NaCl diet in the normal appearing placentas suggesting hypoxia 
and rescue by high NaCl intake. Consequently, AS-/- necrotic placentas showed 
coagulative necrosis and severe lymphocyte infiltration and elevated levels of 
proinflammatory cytokines MCP-1 and TNFα. 
 Aldosterone plays a central role in the long-term control of extracellular 
volume by adapting renal and extrarenal reabsorption of sodium to blood pressure 
[3]. Thereby, extracellular NaCl and volume is enlarged, blood pressure and organ 
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perfusion increased. AS-/- mice are hypotensive despite highly elevated levels of 
renin and angiotensin II. High salt diet reverses renin and angiotensin II 
abnormalities without increasing blood pressure indicating that the extracellular 
volume status is at least partially normalized [23]. To rescue the possibly reduced 
plasma volume and lower uterine blood flow in AS-/- dams, we treated mice with high 
salt for 12 days before pregnancy until gestational day 18. Both  AS+/+ and AS-/- mice 
responded by increasing SBP suggesting that AS-/- dams also retained salt and fluid 
even though plasma volume was not directly measured.  
 High salt diet had several interesting implications. Next to the blood pressure 
lowering potency in pregnant wild-type mice, it partially rescued the fetal phenotype 
with a substantial effect on fetal weight, placental hypoxia, and placental efficiency in 
both AS+/+ and   AS-/- dams. Placental efficiency can be altered experimentally by 
manipulation of uterine blood flow, oxygen availability, and by the intake and 
composition of maternal diet. Increased efficiency is also seen in naturally small 
relative to large placentas in pigs, sheep, goats, rats and mice. Placental efficiency in 
these polytocous species is positively related to litter size [11]. We found that smaller 
placentas in AS+/+ dams on high salt diet and AS-/- dams were associated with larger 
litter size indicating positive correlation between placental efficiency and litter size. 
Decreased placenta weight with larger litter size in AS+/+ dams on high salt diet also 
suggests increased placental efficiency thus supporting an unrestricted fetal growth. 
While small, dark placentas were still observed in AS-/- dams on high salt diet similar 
to control diet it remains amenable a consequence of altered local aldosterone 
availability to support placental development. 
 Limitations of this model of aldosterone deficiency are the high renin and 
angiotensin II levels which may trigger local dysregulatory events in preeclampsia. In 
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the absence of aldosterone synthase, deoxycorticosterone, corticosterone and some 
18-hydroxycorticosterone are still synthesized via 11β-hydroxylase activity. Thus, the 
live-long inhibition of aldosterone synthesis in these animals potentially allowing for 
alternative mineralocorticoid active steroid hormones might have supplemented 
some extrarenal aldosterone effects or even enhanced the inhibition of proliferation 
of trophoblasts via the activation of glucocorticoid receptors.  
Aldosterone availability appears an important prerequisite to support normal feto-
placental development. AS-/- dams had a feto-placental phenotype with decreased 
litter size, smaller placentas and fetuses, yet no overt preeclampsia. In the absence 
of aldosterone, the fetal phenotype might be rescued in part by high salt diet. In wild-
type mice, the high salt diet led to profound blood pressure reduction in pregnancy 
which suggests an important role of plasma volume and placental perfusion for 
maternal well-being. Thus, the absence of aldosterone cannot trigger preeclampsia-
like symptoms in mice, but might well contribute to the development of preeclampsia-
related intrauterine growth restriction while preeclampsia needs to be triggered by 
additional factors. Thus, our study supports the importance of aldosterone in 
placental function in-vivo and a possible role for high salt supplementation in 
pregnancies specifically associated with hypoaldosteronism or reduced plasma 
volume expansion to maintain feto-placental integrity. In contrast, in preeclampsia, 
the benefits of salt supplementation are still controversial and has no major impact 
on outcome as indicated by a recent meta-analysis  [7].  
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FIGURE LEGENDS 
Figure 1. Systolic blood pressure (SBP), proteinuria and litter size on control 
diet.  
A. SBP measured during the course of pregnancy from day 0 to day 21 in AS+/+ 
(n=6-9 animals/ time point) and AS-/- (n=3-9 animals/time point) dams. B. Urine total 
protein concentration normalised to creatinine concentration measured from spot 
urine during pregnancy in AS+/+ (n = 8) and AS-/- dams (n = 6). C. Number of pups 
counted on the day of delivery in AS+/+ (n = 9) and AS-/- (n = 9) dams. Values are 
means ± SEM. *P < 0.05, **P < 0.005, ***P < 0.001 vs.  AS+/+. 
Figure 2. Litter size, litter and placenta weights, and healthy and necrotic 
placentas in AS+/+ and AS-/- dams on day 18 of pregnancy.  
A. Number of fetuses and necrotic placentas were counted in the uterus from AS+/+ 
(n = total number of fetuses and placentas from 8 females) and AS-/- dams (n = total 
number of fetuses and placentas from 15 females). B. Photos of fetuses and 
placentas  in the uterus from AS+/+ and AS-/- dams and comparison of healthy and 
necrotic placenta. C. Mean litter and mean placenta weight versus litter size in AS+/+ 
(n = 8 litters) and AS-/- dams (n = 12 litters). Values are means ± SEM. **P < 0.005, 
***P < 0.001 vs.  AS+/+. 
Figure 3. Histology of placentas  
A. Cross section and HE stain of a placenta from an AS+/+ dam, and healthy  and 
necrotic placentas from AS-/- dams. Bar = 2000 µM. B. Higher magnification of boxed 
area from figure 3A. Bar = 200 µM. DB = decidua basalis, JZ = junctional zone and 
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LZ = labyrinth zone. * indicates lymphocyte infiltration and # indicates coagulative 
necrosis. 
Figure 4. Effect of high salt diet on systolic blood pressure (SBP), litter size, 
litter and placenta weight and necrotic placentas at day 18 of pregnancy  
A. SBP was measured at different time points (days) before and during pregnancy in 
AS+/+ (n = 6-8 animals/time point) and AS-/- (n = 7-10 animals/ time point). B. In AS-/- 
mice, no differences in SBP was observed upon salt loading in pregnancy.  C. In 
pregnant wild-type mice, salt loading led to a significant drop in SBP. For figure B 
and C SBP compared between control and high salt (5 % NaCl) diet at different time 
points just before pregnancy (-4 to -1 day for control and -10 to -8 for high salt), at 
gestational day 5 to 7 and 15 to 17. Values are means ± SEM. *P < 0.05, **P < 
0.005, ***P < 0.001 vs.  AS+/+ (Figure 4A) or vs. control diet (Figure 4B, C) , ###P < 
0.005 vs. high salt (5 % NaCl) at -10 to -1 days.  
Figure 5. Effect of high salt diet on litter size, litter and placenta weight and 
necrotic placentas at day 18 of pregnancy  
A. Number of fetuses and necrotic placentas detected in AS+/+ (n = 6) and AS-/- dams 
(n = 9) at day 18 of pregnancy (P = 0.088). B. Mean litter and mean placenta weight 
versus litter size in AS+/+ (n = 6) and AS-/- dams (n = 9) (P = 0.015). Values are 
means ± SEM. *P < 0.05 vs.  AS+/+.  
Figure 6. Comparison of litter and placenta weights, and placental efficiency 
between control vs. high salt diet in AS+/+ and AS-/- dams.  
Mean litter weights (A) and mean placenta weights (B) on control diet  vs. high salt 
diet  in AS+/+ (control diet n = 8 litters, high salt diet n = 6 litters) and AS-/- dams 
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(control diet n = 12 litters, high salt diet n = 9 litters). C. Placental efficiency in AS+/+ 
(control diet n = 8 litters, high salt diet n = 6 litters) and AS-/- (control diet n = 13 
litters, high salt diet n = 9 litters) dams on control and high salt diet. Values are 
means ± SEM. *P < 0.05, **P < 0.005, ***P < 0.001 vs. control diet, ## P < 0.005 vs. 
AS+/+ on control diet,  ɸɸɸ P < 0.001 vs. AS-/- on control diet . 
Figure 7. Expression of VEGF, sflt and HIF1α in placentas.  
mRNA expression of HIF1α  (A) VEGF (B), and sFlt (C) in healthy placentas from 
AS+/+ (n = 5) and AS-/- (n=4-5 ) dams on control and high salt (5 % NaCl) diet.  
Figure 8. Expression of inflammatory markers MCP-1 and TNFα in placentas. 
mRNA expression of MCP-1 and TNFα was tested by qPCR in healthy placentas 
from AS+/+ (n = 5), and healthy and necrotic placentas from AS-/- (n = 5 each) dams 
on control (A) and high salt (5 % NaCl) (B) diet. Values are means ± SEM. *P < 0.05 
and ***P < 0.001 vs. healthy placentas from AS-/-,   **P < 0.005 and ***P < 0.001 vs. 
AS+/+.  
Figure 9. Protein expression of HIF1α in placentas. 
The protein abundance of HIF1αwas examined in placentas from AS+/+ and AS-/- 
dams on control (A) and high salt (5 % NaCl) (B) diet. Hypoxic (0.2 % oxygen for 16 
hours) and normoxic (20 % oxygen for 16 hours) control samples were collected 
from Mouse Embryonic Fibroblasts (MEFs) cell culture as positive controls. Bar 
graph summarize the results from two independent blots of n= 6 normalized to -
actin measured on the same membranes. Values are means ± SEM. **P < 0.005 vs. 
AS+/+.   
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